Zaid Haddad

2.8k total citations · 1 hit paper
43 papers, 1.2k citations indexed

About

Zaid Haddad is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Zaid Haddad has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 14 papers in Cancer Research and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Zaid Haddad's work include Prostate Cancer Treatment and Research (31 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Cancer, Lipids, and Metabolism (8 papers). Zaid Haddad is often cited by papers focused on Prostate Cancer Treatment and Research (31 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Cancer, Lipids, and Metabolism (8 papers). Zaid Haddad collaborates with scholars based in United States, Canada and Grenada. Zaid Haddad's co-authors include Elai Davicioni, Christine Buerki, Kasra Yousefi, Eric A. Klein, R. Jeffrey Karnes, Nicholas Erho, Voleak Choeurng, Robert B. Jenkins, Ismael A. Vergara and Mercedeh Ghadessi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Zaid Haddad

41 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

2013 427 citations Nicholas Erho, Anamaria Crisan et al. PLoS ONE profile →

Peers

Countries citing papers authored by Zaid Haddad

Since Specialization

Citations

This map shows the geographic impact of Zaid Haddad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zaid Haddad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zaid Haddad more than expected).

Fields of papers citing papers by Zaid Haddad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zaid Haddad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zaid Haddad. The network helps show where Zaid Haddad may publish in the future.

Co-authorship network of co-authors of Zaid Haddad

This figure shows the co-authorship network connecting the top 25 collaborators of Zaid Haddad. A scholar is included among the top collaborators of Zaid Haddad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zaid Haddad. Zaid Haddad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MA23.03 Risk Assessment for Indeterminate Pulmonary Nodules Using a Novel, Plasma-Protein Based Biomarker Assay 2018 ·Journal of Thoracic Oncology ·(unknown), Anil Vachani, (unknown), Luis F. Carbonell, Zaid Haddad, (unknown), (unknown), B. Patel, Heng Yu, Alan H.B. Wu, Pierre P. Massion, Mehrdad Arjomandi, James K. Brown, (unknown), (unknown)	3
2	Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assay 2018 ·PubMed ·Neil N. Trivedi, Mehrdad Arjomandi, James K. Brown, (unknown), (unknown), (unknown), (unknown), (unknown), Yu Heng, Luis F. Carbonell, (unknown), (unknown), Bhavin Patel, Shan Wang, (unknown), Zaid Haddad, Alan H.B. Wu	11
3	Gene Expression Correlates of Site-specific Metastasis Among Men With Lymph Node Positive Prostate Cancer Treated With Radical Prostatectomy: A Case Series 2017 ·Urology ·Vidit Sharma, Kasra Yousefi, Zaid Haddad, Christine Buerki, Robert B. Jenkins, Elai Davicioni, R. Jeffrey Karnes	2
4	Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk 2016 ·Urology ·Eric A. Klein, Zaid Haddad, Kasra Yousefi, Lucia L.C. Lam, Qiqi Wang, Voleak Choeurng, Beatrix Palmer-Aronsten, Christine Buerki, Elai Davicioni, Jianbo Li, Michael W. Kattan, Andrew J. Stephenson, Cristina Magi‐Galluzzi	121
5	Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis 2016 ·Research and Reports in Urology ·Christopher Kane, (unknown), Kasra Yousefi, Zaid Haddad, Firas Abdollah, Lucia L.C. Lam, Heesun Shin, Mohammed Alshalalfa, (unknown), Song Wang, Ahmed Shabaik, Elai Davicioni	13
6	Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk 2016 ·Prostate Cancer and Prostatic Diseases ·Ashley E. Ross, Robert B. Den, Kasra Yousefi, Bruce J. Trock, Jeffrey J. Tosoian, Elai Davicioni, Darby J. S. Thompson, Voleak Choeurng, Zaid Haddad, Phuoc T. Tran, Edouard J. Trabulsi, Leonard G. Gomella, Costas D. Lallas, Firas Abdollah, Felix Y. Feng, Eric A. Klein, Adam P. Dicker, Stephen J. Freedland, R. Jeffrey Karnes, Edward M. Schaeffer	18
7	Development and validation of genomic signature to predict ADT treatment failure. 2016 ·Journal of Clinical Oncology ·Jeffrey Karnes, Hussam Al-Deen Ashab, Bruce J. Trock, Ashley E. Ross, Harrison Tsai, Jeffrey J. Tosoian, Mohammed Alshalalfa, Voleak Choeurng, Kasra Yousefi, Zaid Haddad, Firas Abdollah, Eric A. Klein, Paul L. Nguyen, Felix Y. Feng, Adam P. Dicker, Robert B. Den, Elai Davicioni, Tamara L. Lotan, Edward M. Schaeffer	1
8	730 Decipher genomic classifier measured on prostate biopsy predicts 10 year metastasis risk 2016 ·European Urology Supplements ·Eric A. Klein, Zaid Haddad, Kasra Yousefi, Lucia L.C. Lam, (unknown), Voleak Choeurng, Beatrix Palmer-Aronsten, Christine Buerki, Elai Davicioni, (unknown), Michael W. Kattan, Andrew J. Stephenson, C. Magi-Galluzzi	0
9	Efficacy of early and delayed radiation in a prostatectomy cohort adjusted for genomic and clinical risk. 2016 ·Journal of Clinical Oncology ·Robert B. Den, Kasra Yousefi, Bruce J. Trock, Elai Davicioni, Jeffrey J. Tosoian, Darby J. S. Thompson, Voleak Choeurng, Zaid Haddad, Phuoc T. Tran, Edouard J. Trabulsi, Leonard G. Gomella, Costas D. Lallas, Firas Abdollah, Felix Y. Feng, Adam P. Dicker, Stephen J. Freedland, Jeffrey Karnes, Edward M. Schaeffer, Ashley E. Ross	1
10	435 Efficacy of early and delayed radiation in a prostatectomy cohort adjusted for genomic and clinical risk 2016 ·European Urology Supplements ·Ashley E. Ross, Robert B. Den, Kasra Yousefi, Bruce J. Trock, Elai Davicioni, Jeffrey J. Tosoian, Debrah M. Thompson, Voleak Choeurng, Zaid Haddad, (unknown), Edouard J. Trabulsi, Leonard G. Gomella, (unknown), Firas Abdollah, (unknown), Adam P. Dicker, Stephen J. Freedland, (unknown), (unknown)	1
11	MP14-12 EFFICACY OF EARLY AND DELAYED RADIATION IN A PROSTATECTOMY COHORT ADJUSTED FOR GENOMIC AND CLINICAL RISK 2016 ·The Journal of Urology ·Ashley E. Ross, Robert B. Den, Kasra Yousefi, Bruce J. Trock, Elai Davicioni, Jeffrey J. Tosoian, Darby J. S. Thompson, Voleak Choeurng, Zaid Haddad, Phuoc T. Tran, Edouard J. Trabulsi, Leonard G. Gomella, Costas D. Lallas, Firas Abdollah, Felix Y. Feng, Adam P. Dicker, Stephen J. Freedland, (unknown), Edward M. Schaeffer	1
12	Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas 2015 ·Clinical Cancer Research ·Harrison Tsai, Carlos L. Morais, Mohammed Alshalalfa, (unknown), Zaid Haddad, Jessica Hicks, (unknown), Jonathan I. Epstein, George J. Netto, William B. Isaacs, Jun Luo, Rohit Mehra, Robert L. Vessella, R. Jeffrey Karnes, Edward M. Schaeffer, Elai Davicioni, Angelo M. De Marzo, Tamara L. Lotan	46
13	Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes 2015 ·European Urology ·Scott A. Tomlins, Mohammed Alshalalfa, Elai Davicioni, Nicholas Erho, Kasra Yousefi, Shuang G. Zhao, Zaid Haddad, Robert B. Den, Adam P. Dicker, Bruce J. Trock, Angelo M. De Marzo, Ashley E. Ross, Edward M. Schaeffer, Eric A. Klein, Cristina Magi‐Galluzzi, R. Jeffrey Karnes, Robert B. Jenkins, Felix Y. Feng	101
14	Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting 2015 ·The Journal of Urology ·Andrew G. Glass, Michael C. Leo, Zaid Haddad, Kasra Yousefi, Marguerite du Plessis, Chuhe Chen, Voleak Choeurng, Firas Abdollah, Bruce A. Robbins, Seong Ra, Kathryn Richert-Boe, Christine Buerki, (unknown), Elai Davicioni, Sheila Weinmann	27
15	Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer 2015 ·Journal of Clinical Oncology ·Kosj Yamoah, Michael H. Johnson, Voleak Choeurng, Farzana A. Faisal, Kasra Yousefi, Zaid Haddad, Ashley E. Ross, (unknown), Robert B. Den, Priti Lal, Michael Feldman, Adam P. Dicker, Eric A. Klein, Elai Davicioni, Timothy R. Rebbeck, Edward M. Schaeffer	101
16	A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy 2014 ·European Urology ·Eric A. Klein, Kasra Yousefi, Zaid Haddad, Voleak Choeurng, Christine Buerki, Andrew J. Stephenson, Jianbo Li, Michael W. Kattan, Cristina Magi‐Galluzzi, Elai Davicioni	123
17	Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer 2014 ·JNCI Journal of the National Cancer Institute ·Anirban P. Mitra, Lucia L.C. Lam, Mercedeh Ghadessi, Nicholas Erho, Ismael A. Vergara, Mohammed Alshalalfa, Christine Buerki, Zaid Haddad, Thomas Sierocinski, Timothy J. Triche, Eila C. Skinner, Elai Davicioni, Siamak Daneshmand, Peter C. Black	37
18	Whole-Transcriptome Profiling of Thyroid Nodules Identifies Expression-Based Signatures for Accurate Thyroid Cancer Diagnosis 2013 ·The Journal of Clinical Endocrinology & Metabolism ·Sam M. Wiseman, Zaid Haddad, Blair Walker, Ismael A. Vergara, Thomas Sierocinski, Anamaria Crisan, Mercedeh Ghadessi, Phuong Dao, Benedikt Zimmermann, Timothy J. Triche, Nicholas Erho, Elai Davicioni	15
19	Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy breakdown → 2013 ·PLoS ONE ·Nicholas Erho, Anamaria Crisan, Ismael A. Vergara, Anirban P. Mitra, Mercedeh Ghadessi, Christine Buerki, Eric J. Bergstralh, Thomas M. Kollmeyer, Stephanie Fink, Zaid Haddad, Benedikt Zimmermann, Thomas Sierocinski, Karla V. Ballman, Timothy J. Triche, Peter C. Black, R. Jeffrey Karnes, George G. Klee, Elai Davicioni, Robert B. Jenkins	427
20	Development and validation of a digital Gleason score biomarker signature for risk stratification of patients with prostate cancer. 2012 ·Journal of Clinical Oncology ·Nicholas Erho, Ismael A. Vergara, Christine Buerki, Mercedeh Ghadessi, Anamaria Crisan, Thomas Sierocinski, Zaid Haddad, Benedikt Zimmermann, (unknown), (unknown), Timothy J. Triche, Robert B. Jenkins, Elai Davicioni	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact